Module 1U.S. equity premium (1900–2020)4.3% / yr
Module 1Bond premium over bills~1% / yr
Module 1Short-selling: initial margin50%
Module 1Short-selling: maintenance margin30%
Module 1Avg. individual investor portfolio size4 stocks
Module 1Home bias (individual investors)90%
Module 1Annual portfolio turnover (individuals)75%
Module 1Fama-French size premium (SMB)~2% / yr
Module 1Fama-French value premium (HML)~3.5% / yr
Module 1Momentum premium (WML)~7% / yr
Module 2BioTechCo reported ROIC43.9%
Module 2BioTechCo adjusted ROIC29.6%
Module 2Apple FY24 gross cash$156.6B
Module 2Apple FY24 net debt−$50B
Module 2CompUSA trademark liquidation multiple0.01×
Module 2Danskin trademark liquidation multiple0.23×
Module 2Pharma R&D amortisation life8–10 yrs
Module 2Tech/software R&D amortisation life3–5 yrs
Module 3Mandatory bid threshold (France/UK)30%
Module 3Typical acquisition premium20–40%
Module 3Break-up fee (standard)2–3% of EV
Module 3Reverse termination fee3–8% of EV
Module 3R&W insurance premium2–3% of limit
Module 3M&A deals that destroy value~70%
Module 3Air Liquide / Airgas bridge loan$12B
Module 3Smith & Wesson announced EV$1,800M
Module 3Smith & Wesson equity value (after bridge)$1,300M